SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Art Pappas will join the panel, "The Research, Funding and Product Continuum" at the Southeast Venture Philanthropy Summit.
News | 03. 20. 2013
Art Pappas will join the panel, "The Research, Funding and Product Continuum" at the Southeast Venture Philanthropy Summit.
